{
  "slug": "eatris",
  "name": "Eatris",
  "description": "EATRIS is the European infrastructure for translational medicine. We bring together resources and services for research communities to translate scientific discoveries into benefits for patients. We are a non-profit organisation that provides access to a vast array of expertise and facilities from over 175 top-tier academic centres across Europe. We focus on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcome barriers to health innovation.",
  "url": "https://optimly.ai/brand/eatris",
  "websiteUrl": "https://eatris.eu/",
  "logoUrl": "https://logo.clearbit.com/eatris.eu",
  "baiScore": null,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Drug Discovery and Development Services",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-27T16:16:35.101Z",
  "verifiedVitals": {
    "website": "https://eatris.eu",
    "category": "European infrastructure for translational medicine",
    "what_it_does": "EATRIS is the European infrastructure for translational medicine that brings together resources and services for research communities to translate scientific discoveries into benefits for patients. It focuses on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcoming barriers to health innovation.",
    "primary_audience": "Research communities, academia, industry (biotech SMEs and pharmaceutical companies), public funding agencies, charities, policy makers, and rare disease researchers.",
    "core_product": "Research services for translational medicine, including fostering industry-academia collaborations, support for funding applications, education and training, regulatory services, expert mentoring for rare disease researchers, health technology assessment, translational feasibility assessment, and an innovation helpdesk.",
    "pricing_model": {
      "kind": "custom",
      "detail": "EATRIS is a non-profit organisation, and its services are likely offered on a custom basis depending on the collaboration or project."
    }
  },
  "intentTags": {
    "problemIntents": [
      "Difficulty in translating scientific discoveries to patient benefits",
      "Inefficient drug, vaccine, and diagnostic development",
      "Barriers to health innovation",
      "Lack of access to scientific & medical expertise and latest technologies for industry",
      "Challenges in strengthening translational potential of research proposals",
      "Need for education and training in translational medicine",
      "Complexity of regulatory issues in biomedical development",
      "Lack of access to regulatory, therapy development expertise, and manufacturing for rare disease researchers",
      "Difficulty in assessing costs and benefits of complex health-related technologies",
      "Challenges in assessing and optimizing translational feasibility of research projects",
      "Need for legal support and partnering advice in research collaboration"
    ],
    "solutionIntents": [
      "Access to translational medicine infrastructure",
      "Research services for preclinical and early clinical development",
      "Facilitation of industry-academia collaborations",
      "Funding application support for researchers",
      "Education and training in translational medicine",
      "Regulatory services and support for biomedical development",
      "Expert mentoring for rare disease research",
      "Health Technology Assessment services",
      "Translational Feasibility Assessment services",
      "Innovation helpdesk for legal and partnering advice"
    ],
    "evaluationIntents": [
      "Translational medicine expertise",
      "Research infrastructure quality",
      "Regulatory guidance for biomedical development",
      "Academic-industry partnership opportunities",
      "Support for grant applications",
      "Rare disease therapy development support",
      "Health technology value assessment",
      "Intellectual property guidance for research",
      "European research collaboration network"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1787902582099
}